EU
FOLD

Emory University’s Amicus Therapeutics FOLD Stock Holding History

Emory University’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-192,533
Closed -$2.4M – 29
2019
Q2 		$2.4M Sell
192,533
-16,321
-8% -$207K 1.69% 20
2019
Q1 		$2.84M Sell
208,854
-9,020
-4% -$110K 2% 4
2018
Q4 		$2.09M Buy
217,874
+15,148
+7% +$167K 1.64% 19
2018
Q3 		$2.45M Buy
202,726
+20,683
+11% +$289K 1.6% 24
2018
Q2 		$2.84M Buy
182,043
+9,377
+5% +$142K 1.89% 11
2018
Q1 		$2.6M Buy
172,666
+37,302
+28% +$568K 1.85% 13
2017
Q4 		$1.95M Buy
135,364
+2,885
+2% +$39.6K 1.67% 22
2017
Q3 		$2M Sell
132,479
-69,878
-35% -$924K 1.58% 11
2017
Q2 		$2.04M Buy
+202,357
New +$1.63M 1.8% 4

Other funds holding FOLD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Emory University's FOLD Position: Q3 2019 in Review

Emory University sold out of Amicus Therapeutics (FOLD) in Q3 2019, closing a stake of 192,533 shares — an estimated $2.4M sold.

Emory University first reported a position in FOLD in Q2 2017 and held it in 9 quarters. The position peaked at $2.84M in Q2 2018. 204 funds tracked by Wall St. Rank hold FOLD as of Q3 2019.

  • Emory University reported no remaining Amicus Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Emory University sold 192,533 Amicus Therapeutics shares in Q3 2019, an estimated $2.4M.
  • Emory University first reported a position in Amicus Therapeutics in Q2 2017 and held it in 9 quarters.
  • Emory University's Amicus Therapeutics position peaked at $2.84M in Q2 2018.
  • 204 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2019.

Based on Emory University's 13F filing for Q3 2019, filed 14 Nov 2019.